Carregant...
Applying Precision to the Management of BRAF-Mutant Metastatic Colorectal Cancer
Identifying the presence or absence of a BRAF(V600E) mutation is paramount for the management of patients with metastatic colorectal cancer (mCRC) as there is distinct predictive and prognostic implications, as well as unique therapeutic approaches for this molecular subtype. Traditional cytotoxic d...
Guardat en:
| Publicat a: | Target Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7583680/ https://ncbi.nlm.nih.gov/pubmed/32889679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-020-00747-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|